Main Markets: Africa , Americas , Asia , Caribbean , East Europe , Europe , Middle East , North Europe , Oceania , Other Markets , West Europe , Worldwide
Exporter:71% - 80%
Certs:COS, ISO9001, ISO14010, FDA
Description:Platelet Inhibitor Prasugrel 150322-43-3,Pharmaceutical Drug Prasugrel CAS 150322-43-3,ADP Receptor P2Y12 Antagonist Prasugrel 150322-43-3